🇺🇸 FDA

Company profile · Sponsor

Disc

Disc Medicine

IRON · NYSE pharma WATERTOWN, MA, USA
Pipeline
24
Drugs
2
Patents
8

Quick answer

Disc (IRON) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker IRON
Exchange NYSE
Company type pharma
Headquarters WATERTOWN, MA, USA
SEC CIK 0001816736

Pipeline (24)

Search pipeline →

  1. -

    Disc

    Resectable colorectal rectal metastases without extrahepatic disease

    phase 3 small molecule active

    1 trial

  2. 89Zr-CED88004S

    Disc

    Large B-cell lymphoma

    phase 3 small molecule active

    1 trial

  3. A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial)

    Disc

    ABC borderline resectable pancreatic cancer

    phase 3 other active

    1 trial

  4. ATOMOXETINE , PAROXETINE , MIANSERIN , VORTIOXETINE , VENLAFAXINE , DESVENLAFAXINE , KETAMINE , CLOMIPRAMINE , DULOXETINE , DOSULEPIN , IMIPRAMINE , AMITRIPTYLINE , ESCITALOPRAM , NORTRIPTYLINE , MILNACIPRAN , SERTRALINE , ESKETAMINE , FLUVOXAMINE , REBOXETINE , FLUOXETINE , TRAZODONE , CITALOPRAM , BUPROPION , AGOMELATINE , MIRTAZAPINE , ESKETAMINE , TIANEPTINE

    Disc

    Major depressive disorder

    phase 3 small molecule active

    1 trial

  5. AchilleS tendinoPathy treated with cortIcosteRoid injEctions.

    Disc

    Achilles tendinopathy

    phase 3 other active

    1 trial

  6. Atomoxetine Aurobindo 40 mg hard capsules, Microcrystalline cellulose gelatin capsule

    Disc

    Parkinson's disease

    phase 3 small molecule active

    1 trial

  7. Bitopertin

    Disc

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial

  8. Bitopertin, Matching Placebo

    Disc

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial

  9. CAPECITABINE

    Disc

    Salivary Duct Carcinoma

    phase 3 small molecule active

    1 trial

  10. CETUXIMAB

    Disc

    oral squamous cell carcinoma

    phase 3 small molecule active

    1 trial

  11. Concurrent chemotherapy

    Disc

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial

  12. DAPAGLIFLOZIN, PLACEBO

    Disc

    Hypomagnesemia due to HNF1beta mutation

    phase 3 small molecule active

    1 trial

  13. DAPAGLIFLOZIN, Placebo for dapagliflozin film-coated tablets 10 mg

    Disc

    Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population

    phase 3 small molecule active

    1 trial

  14. DISC-1459

    Disc

    Erythropoietic Protoporphyria

    phase 3 small molecule active

    2 trials

  15. ETIDRONATE DISODIUM ORAL CAPSULES 400 MG

    Disc

    Pseudoxanthoma Elasticum

    phase 3 small molecule active

    1 trial

  16. Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectie

    Disc

    Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases

    phase 3 small molecule active

    1 trial

  17. Erleada 240 mg film-coated tablets, Erleada 60 mg film-coated tablets, Docetaxel AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Disc

    Metastatic hormone-sensitive prostate cancer

    phase 3 small molecule active

    1 trial

  18. FET

    Disc

    ACTH-dependent hypercortisolism

    phase 3 small molecule active

    1 trial

  19. FLUOROURACIL , CAPECITABINE , Folikabi 10 mg/ml oplossing voor injectie/infusie, OXALIPLATIN

    Disc

    Rectal cancer

    phase 3 small molecule active

    1 trial

  20. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc

    Endometrial cancer, uterine cancer

    phase 3 small molecule active

    1 trial

  21. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc

    Carcinoma of the parotid gland

    phase 3 small molecule active

    1 trial

  22. GALLIUM (68GA) GOZETOTIDE , Zr-DFO-girentuximab, Gallium (68Ga) PSMA-11 (gozetotide) prepared using PSMA-11 Sterile Cold Kit

    Disc

    Metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial

  23. Glucose 5% 50 ml

    Disc

    Apnea of prematurity

    phase 3 small molecule active

    1 trial

  24. HEPARIN , NADROPARIN

    Disc

    All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

    phase 3 small molecule active

    1 trial

Drugs (2)

Search drugs →

  1. chymopapain

    CHYMODIACTIN

    INJECTION approved

  2. methimazole

    METHIMAZOLE

    ORAL approved

Patents (8)

Search patents →

  1. US 12427173

    Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12428415

    Matriptase 2 inhibitors and uses thereof

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12421236

    Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12421231

    Azaindole derivatives and their use as ERK kinase inhibitors

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12420085

    Synergistic therapies for inter vertebral disc degeneration

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12403069

    Adapter for use in a planetary mixer

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12398179

    Nanomolar peptides and derivatives to differentially modulate ephrin receptors

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12396924

    Adapter for use in a planetary mixer

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Disc?

Disc (IRON) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does Disc sponsor?

We track 24 ClinicalTrials.gov-linked programs for Disc, including - and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Disc company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.